Emerging Treatments for Skin Cancer and Post Treatment Care
Skin cancer is one of the most common malignancies worldwide, encompassing melanoma and non-melanoma types such as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). While early-stage disease is often curable with surgical excision, advanced or metastatic disease historically carried a poor prognosis. Recent years have seen a significant transformation in the treatment landscape. Immunotherapy—particularly immune checkpoint inhibitors—has revolutionised outcomes, especially in melanoma, by enhancing the body’s immune response against tumour cells.
.jpg)
Learning Outcomes
What you'll learn
- Describe the major types of skin cancer and their treatment pathways.
- Understand emerging therapies including immunotherapy and targeted therapy.
- Identify appropriate candidates for advanced treatments.
- Recognise treatment-related adverse effects and complications.
- Implement post-treatment monitoring and follow-up strategies.
- Provide patient education and preventive care to reduce recurrence risk.
Stay updated with our


Learning Outcomes
What you'll learn
- Describe the major types of skin cancer and their treatment pathways.
- Understand emerging therapies including immunotherapy and targeted therapy.
- Identify appropriate candidates for advanced treatments.
- Recognise treatment-related adverse effects and complications.
- Implement post-treatment monitoring and follow-up strategies.
- Provide patient education and preventive care to reduce recurrence risk.
Stay updated with our


Training Overview
- Overview of Skin Cancer and Traditional Treatments
- Immunotherapy in Skin Cancer
- Targeted Therapy and Precision Medicine
- Emerging and Future Therapies
- Post-Treatment Care and Monitoring
- Patient Education and Preventive Strategies
- Summary
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
Top reviews
No reviews yet.
You May Also Like
Are you a qualified
Trainer or Instructor?
Join Care Learning as a trainer and deliver high-quality courses to learners across healthcare and workplace training.
Refer a Friend &
Earn Rewards.
Invite healthcare professionals to join Care Learning and get rewarded when your referral successfully joins.
Frequently asked questions
Immunotherapy, especially checkpoint inhibitors, has significantly improved outcomes.
Treatment that targets specific genetic mutations in cancer cells.
BRAF mutation.
Drugs that enable the immune system to attack cancer cells.
To detect recurrence and manage complications early.
Through sun protection and regular skin checks.
.jpg)
.jpg)
.jpg)



